Literature DB >> 32430796

Stability Assessment of Intracranial Aneurysms Using Machine Learning Based on Clinical and Morphological Features.

Wei Zhu1, Wenqiang Li1, Zhongbin Tian1, Yisen Zhang1, Kun Wang1, Ying Zhang1, Jian Liu2, Xinjian Yang3.   

Abstract

Machine learning (ML) as a novel approach could help clinicians address the challenge of accurate stability assessment of unruptured intracranial aneurysms (IAs). We developed multiple ML models for IA stability assessment and compare their performances. We enrolled 1897 consecutive patients with unstable (n = 528) and stable (n = 1539) IAs. Thirteen patient-specific clinical features and eighteen aneurysm morphological features were extracted to generate support vector machine (SVM), random forest (RF), and feed-forward artificial neural network (ANN) models. The discriminatory performances of the models were compared with statistical logistic regression (LR) model and the PHASES score in IA stability assessment. Based on the receiver operating characteristic (ROC) curve and area under the curve (AUC) values for each model in the test set, the AUC values for RF, SVM, and ANN were 0.850 (95% CI 0.806-0.893), 0.858 (95 %CI 0.816-0.900), and 0.867 (95% CI 0.828-0.906), demonstrating good discriminatory ability. All ML models exhibited superior performance compared with the statistical LR and the PHASES score (the AUC values were 0.830 and 0.589, respectively; RF versus PHASES, P < 0.001; RF versus LR, P = 0.038). Important features contributing to the stability discrimination included three clinical features (location, sidewall/bifurcation type, and presence of symptoms) and three morphological features (undulation index, height-width ratio, and irregularity). These findings demonstrate the potential of ML to augment the clinical decision-making process for IA stability assessment, which may enable more optimal management for patients with IAs in the future.

Entities:  

Keywords:  Artificial intelligence; Intracranial aneurysms; Machine learning; Risk evaluation; Unstable aneurysm

Year:  2020        PMID: 32430796     DOI: 10.1007/s12975-020-00811-2

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  6 in total

1.  Machine Learning and Intracranial Aneurysms: From Detection to Outcome Prediction.

Authors:  Vittorio Stumpo; Victor E Staartjes; Giuseppe Esposito; Carlo Serra; Luca Regli; Alessandro Olivi; Carmelo Lucio Sturiale
Journal:  Acta Neurochir Suppl       Date:  2022

2.  Classifying Ruptured Middle Cerebral Artery Aneurysms With a Machine Learning Based, Radiomics-Morphological Model: A Multicentral Study.

Authors:  Dongqin Zhu; Yongchun Chen; Kuikui Zheng; Chao Chen; Qiong Li; Jiafeng Zhou; Xiufen Jia; Nengzhi Xia; Hao Wang; Boli Lin; Yifei Ni; Peipei Pang; Yunjun Yang
Journal:  Front Neurosci       Date:  2021-08-11       Impact factor: 4.677

3.  Case Report: The Different Fates of Three Aneurysms: Diagnosis and Treatment Strategies for Unruptured Intracranial Aneurysms With Other Intracranial Diseases.

Authors:  Gaochao Guo; Liming Zhao; Ruiyu Wu; Bingqian Xue; Shao Zhang; Hao Liang; Tao Gao; Yuxue Sun; Yang Liu; Chaoyue Li
Journal:  Front Surg       Date:  2022-05-10

Review 4.  Robotics and Artificial Intelligence in Endovascular Neurosurgery.

Authors:  Javier Bravo; Arvin R Wali; Brian R Hirshman; Tilvawala Gopesh; Jeffrey A Steinberg; Bernard Yan; J Scott Pannell; Alexander Norbash; James Friend; Alexander A Khalessi; David Santiago-Dieppa
Journal:  Cureus       Date:  2022-03-30

Review 5.  Role of Artificial Intelligence in Unruptured Intracranial Aneurysm: An Overview.

Authors:  Anurag Marasini; Alisha Shrestha; Subash Phuyal; Osama O Zaidat; Junaid Siddiq Kalia
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

6.  Prediction and Risk Assessment Models for Subarachnoid Hemorrhage: A Systematic Review on Case Studies.

Authors:  Jewel Sengupta; Robertas Alzbutas
Journal:  Biomed Res Int       Date:  2022-01-27       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.